Tarsus Pharmaceuticals, Inc.(TARS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TARS Tarsus Pharmaceuticals, Inc.

休市中 02-13 16:00:00 EST

60.78

-2.47

-3.91%

盘后60.01

-0.77-1.27%

19:11 EST

最高64.04	最低60.54	成交量55.72万
今开63.85	昨收63.25	日振幅5.53%
总市值25.80亿	流通市值18.45亿	总股本4,245万
成交额3,462万	换手率1.84%	流通股本3,035万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"TARS","market":"US","secType":"STK","nameCN":"Tarsus Pharmaceuticals, Inc.","latestPrice":60.78,"timestamp":1771016400000,"preClose":63.25,"halted":0,"volume":557181,"hourTrading":{"tag":"盘后","latestPrice":60.01,"preClose":60.78,"latestTime":"19:11 EST","volume":14881,"amount":903813.42,"timestamp":1771027889417,"change":-0.77,"changeRate":-0.012669,"amplitude":0.012669},"delay":0,"changeRate":-0.039051383399209466,"floatShares":30351553,"shares":42449105,"eps":-1.992481,"marketStatus":"休市中","change":-2.47,"latestTime":"02-13 16:00:00 EST","open":63.85,"high":64.04,"low":60.54,"amount":34620731.16912,"amplitude":0.055336,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.992481,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1771318800000},"marketStatusCode":7,"adr":0,"listingDate":1602820800000,"exchange":"NASDAQ","adjPreClose":63.25,"preHourTrading":{"tag":"盘前","latestPrice":63.73,"preClose":63.25,"latestTime":"09:29 EST","volume":92,"amount":5798.2595200000005,"timestamp":1770992999911,"change":0.48,"changeRate":0.007589,"amplitude":0.029249},"postHourTrading":{"tag":"盘后","latestPrice":60.01,"preClose":60.78,"latestTime":"19:11 EST","volume":14881,"amount":903813.42,"timestamp":1771027889417,"change":-0.77,"changeRate":-0.012669,"amplitude":0.012669},"volumeRatio":1.0226566096997978,"impliedVol":0.6236,"impliedVolPercentile":0.7888},"requestUrl":"/m/hq/s/TARS/wiki","defaultTab":"wiki","newsList":[{"id":"2593149953","title":"Tarsus Pharmaceuticals, Inc.盘中异动 临近收盘急速拉升5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593149953","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593149953?lang=zh_cn&edition=full","pubTime":"2025-12-20 04:55","pubTimestamp":1766177708,"startTime":"0","endTime":"0","summary":"北京时间2025年12月20日04时55分，Tarsus Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.29%。Tarsus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.52%。其相关个股中，Novabay Pharmaceuticals, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Impact Biomedical, Inc.涨幅较大，Psyence Biomedical Ltd.、In8Bio, Inc.、Neuraxis, Inc.较为活跃，换手率分别为1820.84%、229.78%、141.27%，振幅较大的相关个股有Novabay Pharmaceuticals, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Geovax Labs, Inc.，振幅分别为114.07%、59.87%、57.35%。Tarsus Pharmaceuticals, Inc.公司简介：Tarsus Pharmaceuticals Inc 是一家处于商业化阶段的生物制药公司，从眼部护理开始，专注于开发和商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251220045509953b76cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251220045509953b76cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TARS"],"gpt_icon":0},{"id":"2582435275","title":"Tarsus Pharmaceuticals, Inc.盘中异动 股价大涨5.19%报71.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582435275","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582435275?lang=zh_cn&edition=full","pubTime":"2025-11-11 00:01","pubTimestamp":1762790509,"startTime":"0","endTime":"0","summary":"北京时间2025年11月11日00时01分，Tarsus Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.19%。Tarsus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。其相关个股中，Galecto, Inc.、Cogent Biosciences, Inc.、Pluri Inc.涨幅较大，Galecto, Inc.、Inflarx N.V.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为2080.18%、98.51%、91.16%，振幅较大的相关个股有Galecto, Inc.、Inflarx N.V.、Briacell Therapeutics Corp C/Wts ，振幅分别为169.49%、35.77%、31.62%。Tarsus Pharmaceuticals, Inc.公司简介：Tarsus Pharmaceuticals Inc 是一家处于商业化阶段的生物制药公司，从眼部护理开始，专注于开发和商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111000149976091fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111000149976091fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TARS"],"gpt_icon":0},{"id":"2582135276","title":"Tarsus Pharmaceuticals, Inc.2025财年第三财季实现净利润-12.59百万美元，同比增加46.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582135276","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582135276?lang=zh_cn&edition=full","pubTime":"2025-11-11 00:00","pubTimestamp":1762790434,"startTime":"0","endTime":"0","summary":"11月11日，Tarsus Pharmaceuticals, Inc.公布财报，公告显示公司2025财年第三财季净利润为-12.59百万美元，同比增加46.24%；其中营业收入为1.19亿美元，同比增加147.30%，每股基本收益为-0.30美元。从资产负债表来看，Tarsus Pharmaceuticals, Inc.总负债1.99亿美元，其中短期债务80000.00美元，资产负债比为2.69，流动比率为4.30。机构评级：截至2025年11月11日，当前有8家机构对Tarsus Pharmaceuticals, Inc.目标价做出预测，其中目标均价为84.38美元，其中最低目标价为51.00美元，最高目标价为95.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111000047a497ab1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111000047a497ab1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TARS"],"gpt_icon":0},{"id":"2567190639","title":"生物科技股集体重挫！报道称特朗普政府将儿童死亡甩锅新冠疫苗接种","url":"https://stock-news.laohu8.com/highlight/detail?id=2567190639","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567190639?lang=zh_cn&edition=full","pubTime":"2025-09-13 06:38","pubTimestamp":1757716705,"startTime":"0","endTime":"0","summary":"研发新冠疫苗的BioNTech盘中跌超10%、莫德纳跌超7%、Novavax跌超4%。投资者担心，如果特朗普政府进一步收紧疫苗接种政策，可能对疫苗制造商的业务造成重大冲击，特别是对莫德纳这类高度依赖新冠疫苗收入的公司。更新中","market":"us","thumbnail":"https://static.tigerbbs.com/632b4e916ff966270173f4303843021f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/632b4e916ff966270173f4303843021f"],"rights":{"source":"wallstreetcn_hot_news","url":"https://wallstreetcn.com/articles/3755508","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"ae8bc75ba4d1918dcafc0476d86c6d53","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3755508","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"生物科技股集体重挫！报道称特朗普政府将儿童死亡甩锅新冠疫苗接种","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"wallstreetcn_hot_news","symbols":["MRK","PFE","ARCT","AZN","TARS","NVS","ABUS","PGEN","TVTX","SRPT","STRO","MRNA","NVAX","BNTX","TRVI","BMY","KALV","BK4009","PSNL"],"gpt_icon":1},{"id":"2566661785","title":"计算机行业周报：清华等机构开源强化学习框架RLINF 字节发布原生GUI智能体UI-TARS-2","url":"https://stock-news.laohu8.com/highlight/detail?id=2566661785","media":"华鑫证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566661785?lang=zh_cn&edition=full","pubTime":"2025-09-09 00:00","pubTimestamp":1757347200,"startTime":"0","endTime":"0","summary":"算力： 算力租赁价格平稳，清华等机构开源强化学习框架RLinf9 月1 日，清华大学、北京中关村学院与无问芯穹等机构联合开源了全球首个面向具身智能的大规模强化学习框架RLinf。投资建议2025 年9 月4 日，博通发布2025 财年第三财季财报。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250909142634a4bd67fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250909142634a4bd67fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0069063385.USD","LU0154236417.USD","LU1868837136.USD","LU2279689827.SGD","LU0965509101.SGD","LU1037948897.HKD","BK4515","GO","IE00BYV24P56.USD","LU0256863902.USD","LU2237438978.USD","LU0345769128.USD","LU0640476718.USD","LU1316542783.SGD","LU1992135472.HKD","LU0354030511.USD","LU1670710588.SGD","LU0157215616.USD","LU0274383776.USD","SG9999015978.USD","LU1366333091.USD","LU0912757837.SGD","LU2125154935.USD","LU2322448957.HKD","LU2168564149.EUR","LU0642271901.SGD","LU0353189680.USD","LU1551013342.USD","IE00BKDWB100.SGD","LU1242518857.USD","BK4533","UI","LU0096362180.USD","LU1804176565.USD","AVGO","LU0949170772.SGD","LU0323591593.USD","LU1642822529.SGD","LU0096364046.USD","SG9999015952.SGD","LU1145028129.USD","LU2420271590.USD","LU0348723411.USD","LU0784384876.USD","LU2250418816.HKD","LU0868494617.USD","SG9999001424.SGD","TARS","IE0005OL40V9.USD","IE00BMPRXN33.USD","SG9999002232.USD"],"gpt_icon":1},{"id":"2558691226","title":"Tarsus Pharmaceuticals, Inc.盘中异动 股价大涨5.02%报50.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558691226","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558691226?lang=zh_cn&edition=full","pubTime":"2025-08-11 22:52","pubTimestamp":1754923979,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日22时52分，Tarsus Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.02%。Tarsus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Entero Therapeutics Inc.、Equillium, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Entero Therapeutics Inc.、Equillium, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为5166.76%、415.13%、158.62%，振幅较大的相关个股有Equillium, Inc.、Entero Therapeutics Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为84.05%、74.27%、54.40%。Tarsus Pharmaceuticals, Inc.公司简介：Tarsus Pharmaceuticals Inc 是一家处于商业化阶段的生物制药公司，从眼部护理开始，专注于开发和商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081122525994dcdf26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081122525994dcdf26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TARS"],"gpt_icon":0},{"id":"2518278443","title":"Tarsus Pharmaceuticals, Inc.盘中异动 早盘大幅下挫5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518278443","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518278443?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:01","pubTimestamp":1741615315,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时01分，Tarsus Pharmaceuticals, Inc.股票出现波动，股价急速下挫5.19%。Tarsus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Scisparc Ltd.、Dogwood Therapeutics, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为666.08%、322.06%、92.32%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Scisparc Ltd.、Impact Biomedical, Inc.，振幅分别为41.36%、40.24%、28.59%。Tarsus Pharmaceuticals, Inc.公司简介：Tarsus Pharmaceuticals Inc是一家商业阶段的生物制药公司，从眼部护理开始，专注于治疗药物的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022015598a2a50d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022015598a2a50d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TARS","BK4007"],"gpt_icon":0},{"id":"2517114703","title":"杰富瑞投资银行：维持Tarsus Pharmaceuticals(TARS.US)评级，由买入调整至买入评级, 目标价由54.00美元调整至58.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517114703","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517114703?lang=zh_cn&edition=full","pubTime":"2025-03-07 07:02","pubTimestamp":1741302171,"startTime":"0","endTime":"0","summary":"杰富瑞投资银行：维持Tarsus Pharmaceuticals(TARS.US)评级，由买入调整至买入评级, 目标价由54.00美元调整至58.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/07070248578853.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["TARS"],"gpt_icon":0},{"id":"2517600796","title":"Tarsus Pharmaceuticals, Inc.盘中异动 下午盘股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517600796","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517600796?lang=zh_cn&edition=full","pubTime":"2025-03-05 03:02","pubTimestamp":1741114942,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日03时02分，Tarsus Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.08%。Tarsus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Tarsus Pharmaceuticals, Inc.公司简介：Tarsus Pharmaceuticals Inc是一家商业阶段的生物制药公司，从眼部护理开始，专注于治疗药物的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305030223963984dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305030223963984dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TARS"],"gpt_icon":0},{"id":"2516552737","title":"Tarsus Pharmaceuticals, Inc.2024财年实现净利润-1.16亿美元，同比增加14.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516552737","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516552737?lang=zh_cn&edition=full","pubTime":"2025-03-02 00:00","pubTimestamp":1740844851,"startTime":"0","endTime":"0","summary":"3月2日，Tarsus Pharmaceuticals, Inc.公布财报，公告显示公司2024财年净利润为-1.16亿美元，同比增加14.71%；其中营业收入为1.83亿美元，同比增加948.71%，每股基本收益为-3.07美元。机构评级：截至2025年3月2日，当前有9家机构对Tarsus Pharmaceuticals, Inc.目标价做出预测，其中目标均价为67.33美元，其中最低目标价为45.00美元，最高目标价为85.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250302000104abe2c56e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250302000104abe2c56e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TARS"],"gpt_icon":0},{"id":"2514685738","title":"Guggenheim：维持Tarsus Pharmaceuticals(TARS.US)评级，由买入调整至买入评级, 目标价由75.00美元调整至78.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514685738","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514685738?lang=zh_cn&edition=full","pubTime":"2025-02-27 00:11","pubTimestamp":1740586273,"startTime":"0","endTime":"0","summary":"Guggenheim：维持Tarsus Pharmaceuticals(TARS.US)评级，由买入调整至买入评级, 目标价由75.00美元调整至78.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/27001148413689.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["TARS"],"gpt_icon":0},{"id":"1129601831","title":"异动解读 | Tarsus Pharmaceuticals盘中大涨5.74% 业绩良好成为主因","url":"https://stock-news.laohu8.com/highlight/detail?id=1129601831","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129601831?lang=zh_cn&edition=full","pubTime":"2025-02-26 23:19","pubTimestamp":1740583169,"startTime":"0","endTime":"0","summary":"Tarsus Pharmaceuticals, Inc.(TARS)今日盘中股价大涨5.74%,引发了市场的广泛关注。\n\n从公司业绩来看,最新财报显示Tarsus实现营业收入1.83亿美元,毛利1.70亿美元,净亏损1.16亿美元,每股亏损3.07美元。尽管出现亏损,但营收和毛利都较为可观,表明公司主营业务发展顺利,有望在未来实现盈利。\n\n此外,89%的分析师给予该股买入评级,反映出外界对Tarsus未来前景的乐观预期。该公司旗舰产品XDEMVY是一种创新的治疗蠕形螨眼炎的眼药水,目前处于研究阶段,未来获批上市后有望带来新的利润增长点。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Tarsus Pharmaceuticals盘中大涨5.74% 业绩良好成为主因","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TARS"],"gpt_icon":0},{"id":"2514562678","title":"Tarsus Pharmaceuticals, Inc.盘中异动 股价大涨5.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514562678","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514562678?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:31","pubTimestamp":1740580305,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时31分，Tarsus Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.96%。Tarsus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Enveric Biosciences, Inc.、Nutriband Inc C/Wts 、Channel Therapeutics Corporation涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为2740.08%、114.80%、89.53%，振幅较大的相关个股有Enveric Biosciences, Inc.、Cns Pharmaceuticals, Inc.、Channel Therapeutics Corporation，振幅分别为25.42%、14.35%、10.67%。Tarsus Pharmaceuticals, Inc.公司简介：Tarsus Pharmaceuticals Inc是一家商业阶段的生物制药公司，从眼部护理开始，专注于治疗药物的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262231459893aac6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262231459893aac6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TARS"],"gpt_icon":0},{"id":"1159659327","title":"异动解读 | Tarsus Pharmaceuticals(TARS)盘中狂跌近8%,第四季度亏损扩大引发担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1159659327","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159659327?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:52","pubTimestamp":1740495164,"startTime":"0","endTime":"0","summary":"生物科技公司Tarsus Pharmaceuticals(TARS)股价今日盘中大跌7.77%,引发了市场的广泛关注。这一大跌引发了投资者对该公司前景的担忧。\n\n导致股价大跌的主要原因是,Tarsus Pharmaceuticals刚刚公布了截至2024年12月31日的第四季度财报,季度亏损扩大至2311万美元,相比去年同期的1.31美元收益,出现了转亏。\n\n尽管本季度营收同比大幅增长407.9%至6641万美元,略高于华尔街预期,但公司每股亏损60美分,也超出了分析师预期的每股亏损74美分。该公司股价在过去三个月下跌了17.8%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TARS"],"gpt_icon":0},{"id":"2514090281","title":"Tarsus Pharmaceuticals, Inc.盘中异动 早盘股价大跌6.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514090281","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514090281?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:32","pubTimestamp":1740493957,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时32分，Tarsus Pharmaceuticals, Inc.股票出现异动，股价大幅下跌6.79%。Tarsus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Moleculin Biotech, Inc.、Silexion Therapeutics Corp、Adial Pharmaceuticals, Inc涨幅较大，Gt Biopharma, Inc.、Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为751.75%、467.59%、235.58%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp、Maze Therapeutics, Inc.，振幅分别为20.51%、14.67%、8.87%。Tarsus Pharmaceuticals, Inc.公司简介：Tarsus Pharmaceuticals Inc是一家商业阶段的生物制药公司，从眼部护理开始，专注于治疗药物的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223237abdc7e49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223237abdc7e49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TARS","BK4007"],"gpt_icon":0},{"id":"1102202027","title":"异动解读 | 塔尔苏斯制药公司财报佳绩推动股价盘前大涨9.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=1102202027","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102202027?lang=zh_cn&edition=full","pubTime":"2025-02-25 21:00","pubTimestamp":1740488418,"startTime":"0","endTime":"0","summary":"塔尔苏斯制药公司(TARS)今日在盘前交易中大涨9.24%,引发了市场的广泛关注。这主要受到公司公布了强劲的财报数据所推动。\n\n具体来看,该公司最新一季度的每股亏损为0.60美元,优于分析师预期的每股亏损0.75美元,超出预期水平20%。与去年同期相比,亏损金额也有所改善,降幅达到54.2%。\n\n此外,该公司本季度的销售额达到了66.41百万美元,高于市场预期的58.33百万美元,增长幅度高达13.85%。与去年同期的13.08百万美元销售额相比,销售额更是大幅增长407.86%,显示出公司业务取得了快速增长。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TARS"],"gpt_icon":0},{"id":"1142306559","title":"塔尔苏斯制药公司第四季度GAAP每股收益$(0.60)优于预期$(0.75)，销售额$66.41M超预期$58.33M","url":"https://stock-news.laohu8.com/highlight/detail?id=1142306559","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142306559?lang=zh_cn&edition=full","pubTime":"2025-02-25 20:33","pubTimestamp":1740486794,"startTime":"0","endTime":"0","summary":"塔尔苏斯制药公司报告每股亏损$，优于分析师预期的每股亏损$，超出预期20%。公司报告的季度销售额为$66.41百万，超出了分析师预期的$58.33百万，增长了13.85%。与去年同期销售额为$13.08百万相比，增长了407.86%。以上内容来自Benzinga Earnings专栏，原文如下：Tarsus Pharmaceuticals  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 20 percent. This is a 54.2 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $66.41 million which beat the analyst consensus estimate of $58.33 million by 13.85 percent. ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"塔尔苏斯制药公司第四季度GAAP每股收益$(0.60)优于预期$(0.75)，销售额$66.41M超预期$58.33M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TARS"],"gpt_icon":0},{"id":"2509255988","title":"Tarsus Pharmaceuticals, Inc.盘中异动 股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509255988","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509255988?lang=zh_cn&edition=full","pubTime":"2025-02-06 04:10","pubTimestamp":1738786238,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日04时10分，Tarsus Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.01%。Tarsus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为2.40%。其相关个股中，Immatics N V C/Wts 01/07/2025 、Transcode Therapeutics, Inc.、Invivyd, Inc.涨幅较大，Pasithea Therapeutics Corp.、Transcode Therapeutics, Inc.、Oragenics Inc.较为活跃，换手率分别为4668.77%、2417.31%、1770.76%，振幅较大的相关个股有Oragenics Inc.、Transcode Therapeutics, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为132.24%、99.51%、87.50%。Tarsus Pharmaceuticals, Inc.公司简介：Tarsus Pharmaceuticals Inc是一家商业阶段的生物制药公司，从眼部护理开始，专注于治疗药物的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206041038a23ac112&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206041038a23ac112&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TARS","BK4007"],"gpt_icon":0},{"id":"2508634993","title":"Tarsus Pharmaceuticals, Inc.盘中异动 快速拉升5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508634993","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508634993?lang=zh_cn&edition=full","pubTime":"2025-02-01 01:30","pubTimestamp":1738344618,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日01时30分，Tarsus Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.03%。Tarsus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.79%。其相关个股中，Cyclerion Therapeutics, Inc.、Nls Pharmaceutics Ltd.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Cyclerion Therapeutics, Inc.、Nls Pharmaceutics Ltd.、Silexion Therapeutics Corp较为活跃，换手率分别为2554.47%、1974.52%、189.97%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cyclerion Therapeutics, Inc.、Celularity Inc C/Wts 16/07/2026 ，振幅分别为80.00%、56.30%、53.03%。Tarsus Pharmaceuticals, Inc.公司简介：Tarsus Pharmaceuticals Inc是一家商业阶段的生物制药公司，从眼部护理开始，专注于治疗药物的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201013018961500c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201013018961500c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TARS"],"gpt_icon":0},{"id":"2506309242","title":"Tarsus Pharmaceuticals, Inc.盘中异动 早盘大幅上涨5.02%报51.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506309242","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506309242?lang=zh_cn&edition=full","pubTime":"2025-01-27 23:35","pubTimestamp":1737992148,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日23时35分，Tarsus Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.02%。Tarsus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.24%。其相关个股中，Akero Therapeutics, Inc.、Onconetix, Inc.、89Bio, Inc.涨幅较大，Onconetix, Inc.、Dogwood Therapeutics, Inc.、Evaxion Biotech As较为活跃，换手率分别为1866.96%、280.09%、205.08%，振幅较大的相关个股有Onconetix, Inc.、Dogwood Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为85.35%、69.21%、65.16%。Tarsus Pharmaceuticals, Inc.公司简介：Tarsus Pharmaceuticals Inc是一家商业阶段的生物制药公司，从眼部护理开始，专注于治疗药物的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127233548a2317852&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127233548a2317852&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TARS","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tarsusrx.com","stockEarnings":[{"period":"1week","weight":-0.0594},{"period":"1month","weight":-0.1921},{"period":"3month","weight":-0.1665},{"period":"6month","weight":0.1212},{"period":"1year","weight":0.1637},{"period":"ytd","weight":-0.2577}],"compareEarnings":[{"period":"1week","weight":-0.0128},{"period":"1month","weight":-0.0125},{"period":"3month","weight":0.0146},{"period":"6month","weight":0.0595},{"period":"1year","weight":0.1181},{"period":"ytd","weight":-0.0002}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Tarsus Pharmaceuticals, Inc.是根据特拉华州法律于2016年11月成立的公司。该公司是一家处于临床后期的生物制药公司，致力于治疗性候选药物的开发和商业化，以解决最初存在眼科疾病的巨大市场机遇有限的治疗选择。该公司的主要产品候选产品TP-03是2b/3期的新型疗法，目前正在开发中，用于治疗由蠕形螨引起的眼睑炎，这被称为蠕形螨眼。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.002743},{"month":2,"riseRate":0.166667,"avgChangeRate":-0.000827},{"month":3,"riseRate":0.2,"avgChangeRate":-0.047875},{"month":4,"riseRate":0.6,"avgChangeRate":0.02077},{"month":5,"riseRate":0.6,"avgChangeRate":-0.033136},{"month":6,"riseRate":0.4,"avgChangeRate":-0.04436},{"month":7,"riseRate":0.4,"avgChangeRate":-0.024485},{"month":8,"riseRate":0.8,"avgChangeRate":0.123751},{"month":9,"riseRate":0.8,"avgChangeRate":0.033781},{"month":10,"riseRate":0.8,"avgChangeRate":0.135195},{"month":11,"riseRate":0.666667,"avgChangeRate":0.092511},{"month":12,"riseRate":0.666667,"avgChangeRate":0.122111}],"exchange":"NASDAQ","name":"Tarsus Pharmaceuticals, Inc.","nameEN":"Tarsus Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tarsus Pharmaceuticals, Inc.(TARS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Tarsus Pharmaceuticals, Inc.(TARS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Tarsus Pharmaceuticals, Inc.,TARS,Tarsus Pharmaceuticals, Inc.股票,Tarsus Pharmaceuticals, Inc.股票老虎,Tarsus Pharmaceuticals, Inc.股票老虎国际,Tarsus Pharmaceuticals, Inc.行情,Tarsus Pharmaceuticals, Inc.股票行情,Tarsus Pharmaceuticals, Inc.股价,Tarsus Pharmaceuticals, Inc.股市,Tarsus Pharmaceuticals, Inc.股票价格,Tarsus Pharmaceuticals, Inc.股票交易,Tarsus Pharmaceuticals, Inc.股票购买,Tarsus Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tarsus Pharmaceuticals, Inc.(TARS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Tarsus Pharmaceuticals, Inc.(TARS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}